Brent L. Larson
2012
In 2012, Brent L. Larson earned a total compensation of $495.6K as Executive Vice President and Chief Financial Officer at Navidea Biopharmaceuticals, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $49,555 |
|---|---|
| Option Awards | $169,603 |
| Salary | $265,000 |
| Other | $11,404 |
| Total | $495,562 |
Larson received $265K in salary, accounting for 53% of the total pay in 2012.
Larson also received $49.6K in non-equity incentive plan, $169.6K in option awards and $11.4K in other compensation.
Rankings
In 2012, Brent L. Larson's compensation ranked 8,792nd out of 11,487 executives tracked by ExecPay. In other words, Larson earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,792 out of 11,487 | 24th |
Division Manufacturing | 3,205 out of 4,253 | 25th |
Major group Chemicals And Allied Products | 863 out of 1,198 | 28th |
Industry group Drugs | 634 out of 920 | 31st |
Industry In Vitro and In Vivo Diagnostic Substances | 31 out of 47 | 34th |
Source: SEC filing on June 5, 2015.
Larson's colleagues
We found four more compensation records of executives who worked with Brent L. Larson at Navidea Biopharmaceuticals in 2012.
2012
Mark Pykett
Navidea Biopharmaceuticals
Chief Executive Officer
2012
Thomas Tulip
Navidea Biopharmaceuticals
President and Chief Business Officer
2012
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2012
Rodger Brown
Navidea Biopharmaceuticals